Advertisement

Bill Gates Says US and UK Should Step Up to Aid Nations With Slow Vaccine Programs

The billionaire is hopeful the world will be back to normal by 2022.

Back in August of 2020, billionaire philanthropist Bill Gates gave an in-depth interview to Wired where he stated that the pandemic will end for the rich world by the end of 2021 and for the developing world by the end of 2022.

"The innovation pipeline on scaling up diagnostics, on new therapeutics, on vaccines is actually quite impressive. And that makes me feel like, for the rich world, we should largely be able to end this thing by the end of 2021, and for the world at large by the end of 2022," Gates said.

Now, the founder of Microsoft has repeated a similar sentiment, telling Sky news how he still hopes the world will be back to normal "by the end of 2022." In the interview, he also added that the U.K. and U.S. must help out those countries with slower vaccination programs and discussed the Johnson & Johnson vaccine in particular.

"There are still some questions about how broadly the Johnson & Johnson vaccine will get used," Gates said.

"If that's accepted it would be very beneficial but some of the rich countries including the U.S. and the U.K., even this summer will get to high vaccination levels."

Once that is done, Gates explained it will "free up" these developed nations to work on "getting vaccines out to the entire world in late 2021 and through 2022."

"And so we won't have eradicated this disease but we'll be able to bring it down to very small numbers by the end of 2022," Gates concluded.

These statements by a trusted public figure bring much hope for all who have been affected by the virus. Gates also shared his thoughts that the pandemic would be under control by 2022 last March indicating he has a clear and consistent vision of when things could return "completely back to normal."

Follow Us on

Stay on top of the latest engineering news

Just enter your email and we’ll take care of the rest:

By subscribing, you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.